(MENAFN - America News Hour)In a recently published report, Healthcare Nanotechnology (Nanomedicine) Market report for till 2030. The report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to regain 25% by the end of 2021- Positive Growth in the economic demand and supply.
U S Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analysis and U.S. Census Bureau mention the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) average exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilst imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Healthcare Nanotechnology (Nanomedicine) Market products.
Download Sample of This Strategic Report:
Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth. According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018.
The term Nanotechnology is used when the developments occur at very miniscule 0.1 to 100 nm scale. Nanomedicine is an offshoot of Nanotechnology which basically involves development of medicines at a molecular stage. The medicines ae developed for treatment of life threatening diseases such as cancer, Parkinson, Alzheimer, diabetes, etc. These also have various other applications such as diagnosis, prevention and even regeneration of tissues.
The development of a nanomedicine is a tedious process and usually takes several years. These are based on technologies such as quantum dots, nanorobots, nanorods, nanoparticles, fullerenes, liposomes and more. The diagnosis field has more precise and reliable nanotechnology methods. These require minimum biological sample which facilitates considerable reduction in consumption of reagents and disposables. This technology is also widely used in drug delivery purpose due to nanoscale particles.
A number of factors drive the market for Nanomedicine. The improvement in regulatory framework, the technology becoming more familiar, heavy funding and a positive mindset by the governments of various countries help its cause. Apart from these, a continuous increase in the aforementioned chronic diseases has been observed. Thus, there has been a phenomenal rise in the demand of nanomedicines. With new companies stated to enter the market, the supply-demand gap of nanomedicines will be bridged to a larger extent. There are debates on the toxicity of these medicines and the high cost associated to it but currently, the benefits outweigh the riskinvolved.
The basis of segmentation of this market is applications in medicines, targeted disease and geography. The application segment includes, drug delivery, drugs, biomaterials, active implant, in-vitro diagnostic, and in-vivo imaging where drug delivery contributes higher than rest followed by in-vitro diagnostics. It is divided on the basis of diseases in the following segments: neurology, cardiovascular, oncology, anti-inflammatory, anti-infective and others. Till 2012, the market was heavily dominated by oncology segment however currently, the cardiovascular nanomedicine market is the fastest growing.
The market was heavily dominated by the US but there has been a rise in the Asia Pacific region and is expected to grow faster owing to a rapid increase in geriatric population and rising awareness of healthcare. Even Europe is stated to grow faster than the US due to its extensive product pipeline portfolio and improving regulatory frameworks.
Some of the major players in the market include GE Healthcare, Abbott Laboratories,Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Celgene Corporation, Teva Pharmaceutical Industries Ltd.
Report ContentsRegional AnalysisReport Highlights
Market Drivers, Restraints and Opportunities
Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Market – Current Trends
Competition & Major Companies
Technology and R & D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players
US and Canada
Mexico, Brazil, Argentina and Rest of Latin America
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe
Request For Sample Request:
Rest of Eastern Europe
Australia and New Zealand
Rest of Asia Pacific
Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
Rest of Middle East and Africa
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation.
Phone:+1 313 462 0609
Darlene Dooley is a research expert and freelance writer. She is very dedicated towards her work and writing. She enjoys to write on current news on any industry and conclude the news with highly professional report. She has almost 8 years of experience in the same field. She has strong professional skill in Market research, Business Strategies, online marketing, Industry analysis interested in innovative and trending technologies.
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.